Skip to main content
Top

Breast Cancer Research and Treatment

Issue 2/2008

Content (23 Articles)

Review

Oestrogen producing enzymes and mammary carcinogenesis: a review

Ashok Subramanian, Mohamed Salhab, Kefah Mokbel

Preclinical Study

Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2

Ferdinando Mannello, Wenyi Qin, Weizhu Zhu, Laura Fabbri, Gaetana A. Tonti, Edward R. Sauter

Preclinical Study

Seasonal modulation of post-resection breast cancer metastasis

Eun-Young Oh, Patricia A. Wood, Jovelyn Du-Quiton, William J. M. Hrushesky

Preclinical Study

Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor

Matthias Kotzsch, Anieta M. Sieuwerts, Marianne Grosser, Axel Meye, Susanne Fuessel, Marion E. Meijer-van Gelder, Marcel Smid, Manfred Schmitt, Gustavo Baretton, Thomas Luther, Viktor Magdolen, John A. Foekens

Preclinical Study

Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells

Michele L. Scotti, John F. Langenheim, Seth Tomblyn, Alison E. B. Springs, Wen Y. Chen

Preclinical Study

2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique

Paul A. Foster, Yaik T. Ho, Simon P. Newman, Philip G. Kasprzyk, Mathew P. Leese, Barry V. L. Potter, Michael J. Reed, Atul Purohit

Epidemiology

Adjuvant chemotherapy for breast cancer: a cost-utility analysis of FEC-D vs. FEC 100

Tallal Younis, Daniel Rayson, Marlene Sellon, Chris Skedgel

Epidemiology

Vitamin supplement use and risk for breast cancer: the Shanghai Breast Cancer Study

Tsogzolmaa Dorjgochoo, Martha J. Shrubsole, Xiao Ou Shu, Wei Lu, Zhixian Ruan, Ying Zheng, Hui Cai, Qi Dai, Kai Gu, Yu-Tang Gao, Wei Zheng

Epidemiology

Polymorphisms in three base excision repair genes and breast cancer risk in Thai women

Suleeporn Sangrajrang, Peter Schmezer, Iris Burkholder, Peter Waas, Paolo Boffetta, Paul Brennan, Helmut Bartsch, Surapon Wiangnon, Odilia Popanda

Epidemiology

Benign breast disease heterogeneity: association with histopathology, age, and ethnicity

Jingfang Cheng, Shijing Qiu, Usha Raju, Sandra R. Wolman, Maria J. Worsham

Open Access Epidemiology

On the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk

Isabelle Soerjomataram, Eero Pukkala, Hermann Brenner, Jan Willem W. Coebergh

Epidemiology

Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients

Mieke Kriege, Caroline Seynaeve, Hanne Meijers-Heijboer, J. Margriet Collee, Marian B. E. Menke-Pluymers, Carina C. M. Bartels, Madeleine M. A. Tilanus-Linthorst, Ans van den Ouweland, Bert van Geel, Cecile T. M. Brekelmans, Jan G. M. Klijn

Epidemiology

Paget’s disease of the nipple in a population based cohort

Kristina Dalberg, Henrik Hellborg, Fredrik Wärnberg

Epidemiology

EGF promoter SNPs, plasma EGF levels and risk of breast cancer in Chinese women

Yan Wang, Tian Tian, Zhibin Hu, Jinhai Tang, Shui Wang, Xuechen Wang, Jianwei Qin, Xiang Huo, Jun Gao, Qiao Ke, Guangfu Jin, Hongxia Ma, Xinru Wang, Hongbing Shen

Epidemiology

Is obesity an independent prognosis factor in woman breast cancer?

Bilal Majed, Thierry Moreau, Kamel Senouci, Rémi J. Salmon, Alain Fourquet, Bernard Asselain

Epidemiology

Development of a high sensitivity, nested Q-PCR assay for mouse and human aromatase

Giujian Liu, Yu-sheen Wu, David Brenin, Wei Yue, Sarah Aiyar, Anne Gompel, Ji-Ping Wang, Rajeshwar Rao Tekmal, Richard J. Santen

Erratum

Development of a high sensitivity, nested Q-PCR assay for mouse and human aromatase

Gui-Jian Liu, Yu-sheen Wu, David Brenin, Wei Yue, Sarah Aiyar, Anne Gompel, Ji-Ping Wang, Rajeshwar Rao Tekmal, Richard J. Santen

Clinical Trial

The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method

Katherine H. Rak Tkaczuk, Olga Goloubeva, Nancy S. Tait, Faye Feldman, Ming Tan, Zhao-Ping Lum, Stephen A. Lesko, David A. Van Echo, Paul O. P. Ts’o

Clinical Trial

Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors

N. Lynn Henry, Jon T. Giles, Dennis Ang, Monika Mohan, Dina Dadabhoy, Jason Robarge, Jill Hayden, Suzanne Lemler, Karineh Shahverdi, Penny Powers, Lang Li, David Flockhart, Vered Stearns, Daniel F. Hayes, Anna Maria Storniolo, Daniel J. Clauw

Clinical Trial

Does computer-aided detection (CAD) contribute to the performance of digital mammography in a self-referred population?

Beniamino Brancato, Nehmat Houssami, Damiana Francesca, Simonetta Bianchi, Gabriella Risso, Sandra Catarzi, Renzo Taschini, Marco Rosselli Del Turco, Stefano Ciatto

Clinical Trial

Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer

T. A. Traina, I. Poggesi, M. Robson, A. Asnis, B. A. Duncan, A. Heerdt, C. Dang, D. Lake, M. Moasser, K. Panageas, P. Borgen, L. Norton, C. Hudis, M. N. Dickler

Letter to the Editor

Invasiveness gene signature predicts a favorable outcome also in estrogen receptor-positive primary breast cancers treated with adjuvant tamoxifen

Danila Coradini, Manuela Gariboldi, Maya Fedeli, Marco A. Pierotti, Maria Grazia Daidone

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine